Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Alpha Tau Medical Ltd ( (DRTS) ) is now available.
Alpha Tau Medical Ltd. announced that its CEO and CFO will present a corporate overview at the J.P. Morgan 43rd Annual Healthcare Conference in January 2025. This presentation will highlight recent achievements and future data milestones, potentially impacting investor interest and the company’s market positioning.
More about Alpha Tau Medical Ltd
Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company established in 2016, focusing on the research, development, and potential commercialization of Alpha DaRT, a novel alpha-radiation therapy designed for the treatment of solid tumors. The technology was developed at Tel Aviv University and aims to provide targeted tumor destruction while minimizing damage to surrounding healthy tissue.
YTD Price Performance: 0.66%
Average Trading Volume: 35,324
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $211.9M
For detailed information about DRTS stock, go to TipRanks’ Stock Analysis page.